Stifel Reiterates Buy Rating on Clearpoint Neuro Inc. (CLPT)

June 9, 2026 9:09 AM

Stifel analyst Tom Stephan reiterated a Buy rating and $16.00 price target on Clearpoint Neuro Inc. (NASDAQ: CLPT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found